RPAM
AGL icon

Rhenman & Partners Asset Management’s Agilon Health AGL Stock Holding History

Rhenman & Partners Asset Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,600
Closed -$2.1M – 84
2023
Q1 		$2.1M Sell
3,600
-6,600
-65% -$3.7M 0.23% 76
2022
Q4 		$4.12M Hold
10,200
– – 0.43% 66
2022
Q3 		$5.06M Buy
10,200
+3,600
+55% +$2.16M 0.53% 58
2022
Q2 		$3.6M Buy
+6,600
New +$3.34M 0.41% 64

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Rhenman & Partners Asset Management's AGL Position: Q2 2023 in Review

Rhenman & Partners Asset Management sold out of Agilon Health (AGL) in Q2 2023, closing a stake of 3,600 shares — an estimated $2.1M sold.

Rhenman & Partners Asset Management first reported a position in AGL in Q2 2022 and held it in 4 quarters. The position peaked at $5.06M in Q3 2022. 185 funds tracked by Wall St. Rank hold AGL as of Q2 2023.

  • Rhenman & Partners Asset Management reported no remaining Agilon Health position as of Q2 2023 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 3,600 Agilon Health shares in Q2 2023, an estimated $2.1M.
  • Rhenman & Partners Asset Management first reported a position in Agilon Health in Q2 2022 and held it in 4 quarters.
  • Rhenman & Partners Asset Management's Agilon Health position peaked at $5.06M in Q3 2022.
  • 185 funds tracked by Wall St. Rank held Agilon Health as of Q2 2023.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.